ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,132.15
1.34%
Dow Jones
38,680.11
1.19%
US Dollar vs MXN
16.96375
-0.05%
Brent Oil
82.80
-0.99%
Bitcoin
61,759.20
4.46%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Heron Therapeautics Inc (HRTX)

  7. Heron Therapeautics Inc (HRTX) Noticias

HRTX Heron Therapeautics Inc

2.635
0.085 (3.33%)
Última actualización: 13:50:08
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Heron Therapeautics Inc HRTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.085 3.33% 2.635 13:50:08
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.67 2.57 2.74 2.55
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202407:00PRNUSHeron Therapeutics to Report First Quarter 2024 Financial..
11/4/202415:05PRNUSHeron Therapeutics to Host Investor Day on May 15, 2024 in..
28/3/202415:05PRNUSHeron Therapeutics Announces Presentation at the 23rd Annual..
13/3/202415:25APSBiotech Finds Mid-Week Success Following Q4 Earnings Release
12/3/202415:05PRNUSHeron Therapeutics Announces Fourth Quarter and Full-Year..
12/3/202406:22IHMARKETNEWSGlobal Markets Await U.S. Inflation Report: Mixed Movements..
28/2/202407:00PRNUSHeron Therapeutics to Report Fourth Quarter and Full Year..
14/2/202415:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202408:25APSPremarket Heats Up For Biotech Before Opening Bell
24/1/202407:01EDGAR2Form 8-K - Current report
23/1/202419:00PRNUSHeron Therapeutics Announces FDA Approval of ZYNRELEF®..
19/1/202420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202420:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202420:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202420:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202419:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202415:07EDGAR2Form 8-K - Current report
07/1/202416:00PRNUSHeron Therapeutics Announces Partnership with CrossLink Life..
22/12/202315:30EDGAR2Form 8-K - Current report
21/12/202316:25EDGAR2Form 8-K - Current report
06/12/202315:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21/11/202311:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202309:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202311:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202311:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202311:25APSBiotech Shares Up Sharply Following Quarterly Results
14/11/202315:10EDGAR2Form 8-K - Current report
14/11/202315:05PRNUSHeron Therapeutics Announces Third Quarter 2023 Financial..
07/11/202315:05PRNUSHeron Therapeutics to Report Third Quarter 2023 Financial..
17/10/202318:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202315:08EDGAR2Form S-3 - Registration statement under Securities Act of..
14/8/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:11EDGAR2Form 8-K - Current report
14/8/202315:05PRNUSHeron Therapeutics Announces Second Quarter 2023 Financial..
07/8/202315:05PRNUSHeron Therapeutics to Report Second Quarter 2023 Financial..
01/8/202312:56EDGAR2Form D - Notice of Exempt Offering of Securities
25/7/202315:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202315:13EDGAR2Form SC 13D/A - General statement of acquisition of..
24/7/202308:12EDGAR2Form 8-K - Current report
24/7/202308:02PRNUSHeron Therapeutics Announces Cost Reduction Plan and..
24/7/202308:00PRNUSHeron Therapeutics Announces $30 Million Private Placement..
19/7/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
HRTX
Heron Therapeautics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados